InsideTracker Announces Terra, Taking AI-Driven Real-Time Health Coaching and Recommendations to a New Level.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InsideTracker, a leader in data-driven health technology, is pleased to introduce Terra, a first-of-its-kind virtual coach that enables its members to dive deep into their own body.
Terra builds on the success of Ask InsideTracker, a native AI tool released last year and now one of the platform's most popular features. With this major version update, Terra becomes a personalized health coach with the ability to access information and offer recommendations typically limited to high-end concierge medicine.
'We've been building AI systems for a decade, so the recent energy around this sector has been a tremendous opportunity for us,' said Rony Sellam, CEO of InsideTracker. 'Our members are now able to take advantage of advanced health tools unlike anything else on the market. The real breakthrough here is that these different types of AI are more effective when paired together. It's a huge testament to our engineers and data scientists that we're able to bring this solution to life.'
Terra will have access to InsideTracker's blood-based biomarker data and other vital health information. This includes a users' body composition, sleep habits, supplement intake, fitness tracker data and food and exercise preferences.
Terra answers sensitive questions quickly and develops a deep understanding of how underlying health metrics affect daily life. It can interpret blood results, troubleshoot symptoms, and find solutions that lead to improvements in health metrics. For example, you can ask, 'What is the number one thing I can do to improve my health right now?'
Terra can quickly scan your data and give you a personalized reply. It might say: 'This week, focus on optimizing your sleep. You have three blood biomarkers hurting your body's ability to rest and recover. These are low vitamin D, low magnesium, and high hsCRP.'
From there, Terra can recommend how to get those three biomarkers into the optimal range to effectively improve your sleep and overall health.
Other questions may include:
'How do I lower my thyroid-stimulating hormone?'
'What vitamins should I take based on my blood test?'
'Why have I been feeling so tired lately?'
With access to increasingly rich data, Terra will know a users' individual workout habits, mealtimes, genetic predispositions, and more to build and rebuild personalized health plans tailored to every individual's schedule, preferences, sense of urgency, and physiological needs. When habits or health data change, Terra will be able to guide you back to a healthy, science-backed routine.
InsideTracker members who have participated in our beta testing reported: 'I loved the personal experience, it looked at my health profile and knew what stage of menopause I was in, then looked at my blood results and provided answers to my questions'; 'Terra provided a very intuitive interaction that referenced my results specifically'; 'Informative, got immediate answers to my questions'.
InsideTracker has been pushing boundaries with AI for over 10 years. Its original AI model, SegterraX, is a central feature of InsideTracker's membership plan and is built on a type of AI known as knowledge representation and reasoning (KRR), which is designed to reason like a human expert.
With Terra, InsideTracker merges its KRR with an LLM. This approach creates a powerful Dual AI system that results in greater health insights for members while keeping in place guardrails that prevent AI hallucinations, bad information, and the additional drawbacks that commonly plague other AI models. According to an InsideTracker customer survey, 9 in 10 respondents trust Terra's advice and insights. This signals a significant advantage over other AI models, which often have low consumer trust in regards to health and wellness.
'Terra represents a fundamental shift in how people will interact with their health data,' said Renée Deehan, PhD, InsideTracker's Senior Vice President of Science and AI. 'Unlike a human, AI has infinite patience to work through complex issues, and with this advancement, it can now cross-reference personal health data with peer-reviewed science. It's like having unrestricted access to a team of experts across multiple fields of study.'
Terra is built on OpenAI's GPT-4, but it filters replies through the user's blood data and personal health profile, along with InsideTracker's proprietary library of educational material. This results in a hallucination-free conversation that eliminates the noise of unscientific health advice. It's also completely secure. While Terra knows details about the user's health, it does not have access to their name, DOB, or other identifying information. In addition, InsideTracker is HIPAA compliant and SOC 2 Type II certified for privacy and security.
Terra is the first AI agent focused on health data to provide personalized lifestyle guidance based directly on an individual users' blood, nutrition, and exercise data, in a private and secure service. No chatbot or AI agent has been able to deliver this experience, until now. With access to blood data and other sources of health information, Terra can deliver instant access to clinical expertise to anyone.
About InsideTracker
InsideTracker is the industry leader in health analytics. Through a comprehensive analysis of your blood, DNA, lifestyle, and nutrition habits, it provides personalized recommendations for living longer, looking younger, and achieving peak performance. Its recommendations include nutrition, supplements, and exercise adjustments. Whether you're an athlete, professional, or parent, InsideTracker can deliver peak health in a way that fits seamlessly into your life. www.insidetracker.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
3 hours ago
- Business Wire
The Sun's Out. So Is the Secret to UV and Sun Support from Within.
KAILUA-KONA, Hawaii--(BUSINESS WIRE)--A new conversation in sun care is emerging — one that goes beyond the surface and into the science of supporting skin from within with microalgae. Nutrex Hawaii, a wholly owned subsidiary of Cyanotech Corporation and producer of BioAstin Hawaiian Astaxanthin, is leading that evolution with more than 40 years of natural microalgae cultivation, research, and innovation on Hawaii's Kona Coast. For years, health guidance has focused on external protection - sunscreen, hats, UV clothing, and sunglasses. That's smart. But science has evolved — and so has understanding of support from within. Share 'For years, public health guidance has focused on external protection — sunscreen, shade, hats, protective clothing, and sunglasses. That's smart and we agree. Everyone on our Hawaiian farm follows these practices,' said Collette Kakuk, Chief Strategic Officer at Nutrex Hawaii. 'But science has evolved — and so has our understanding of skin support from within.' The Science Behind the Shield. BioAstin Hawaiian Astaxanthin is one of nature's most powerful antioxidants and works in two ways to help protect skin under the sun: Neutralizes UV-induced free radicals, supporting healthy inflammation response, collagen integrity, and skin elasticity Accumulates in the skin's layers, embedding in cell membranes to deliver continuous, inside-out defense before damage begins With only 6–12mg daily (one small softgel), BioAstin® Hawaiian Astaxanthin® builds resilience and provides antioxidant support from within ☨ after about 3 to 4 weeks. Not a Sunscreen Replacement — A Sun Care Reinforcement Skin cancer is on the rise globally, with the United States consistently ranking among the highest reported cases. According to National Cancer Institute estimates, there were 100,640 new cases of skin melanomas and 8,290 related deaths in the United States in 2024. The American Academy of Dermatology Association estimates that one in five Americans will develop skin cancer in their lifetime. Finally, according to the Skin Cancer Foundation, about 90 percent of nonmelanoma skin cancers are associated with exposure to ultraviolet (UV) radiation from the sun. The following have long been advocated for with regard to sun safety: Using broad-spectrum, reef-safe sunscreen Wearing a wide brimmed hat & protective clothing Wearing UV-blocking sunglasses Seeking shade during peak hours BioAstin® doesn't aim to replace these measures — but to reinforce them. 'Internal support fills a critical gap in modern sun care,' said Kakuk. 'It's not a replacement for sunscreen, but a crucial internal layer of adjunctive UV and sun support for responsible sun care — especially given how sunscreen is used in the real world: it sweats off, washes off, gets missed in spots, or isn't reapplied as often as it should be.' More Than Skin Deep: Full-Body Support for Life Under the Sun As an antioxidant 6,000x stronger than Vitamin C — BioAstin® helps provide internal support against UV and sun exposure ☨ — it's also one of the rare natural antioxidants capable of crossing both the blood-brain and blood-retinal barriers, entering deep into the mitochondria, our cellular engines where energy is produced and oxidative damage is most critical. This extraordinary bioactivity supports a wide range of clinically documented benefits for full-body wellness, including eye, skin, joint, heart, and brain health ☨, as well as post-exercise recovery ☨ and cellular support ☨. 'Here in Hawaii, we've long known BioAstin® provides powerful internal antioxidant support. From beach goers, lifeguards, surfers, and tourists to outdoor workers and healthy agers, we're proud to expand the sun care conversation with superior microalgae that supports the body in much the same way it functions in nature,' said Kakuk. Nature's Blueprint for Sun Defense: Biomimicry in Action In the natural world, the freshwater microalga Haematococcus pluvialis faces harsh environmental stress, including intense UV radiation from the sun. To survive, it produces high levels of astaxanthin, a powerful red carotenoid antioxidant, to form a protective barrier against UV damage and oxidation. This same mechanism is what makes astaxanthin so extraordinary for humans. The way astaxanthin protects microalgae from UV-induced stress in nature is the same way it works within the human body — helping to support skin from within. It's a striking example of biomimicry, where nature's survival strategies are mirrored in how it functions in the body. 'In nature, this unique microalgae survives intense UV stress by producing astaxanthin — a powerful antioxidant and striking example of biomimicry,' said Dr. Gerry Cysewski, PhD, Founder and Chief Scientific Officer of Nutrex Hawaii. 'I've spent my career studying and cultivating these remarkable organisms because of their unique biochemical properties and continually unfolding potential. Supporting our bodies under the sun with the same molecule nature uses to protect its own life forms isn't just smart science — it's common sense.' BioAstin harnesses this biological brilliance with natural astaxanthin farm grown outdoors — never synthetic or bio-identical versions produced in labs under LED lights. BioAstin is cultivated in sustainable, open-air ponds on Hawaii's Kona Coast, where intense natural sunlight triggers the microalga's defense response to produce astaxanthin. A Legacy Rooted in Science, Sustainability, and Hawaii Nutrex Hawaii is one of Hawaii's longest-standing farm-based supplement brands, having sustainably cultivated microalgae on the Kona Coast for over 40 years. Every harvest is traceable, rigorously tested, and grown with care using sustainable aquaculture practices in one of the world's sunniest climates. See Where It's Grown – Video Link About Nutrex Hawaii: For over 40 years, Nutrex Hawaii has sustainably cultivated microalgae to support health and wellness. Grown on a purpose-built 96-acre farm on the pristine Kona Coast of Hawaii, its flagship products— BioAstin® Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica® —are trusted worldwide. Nutrex Hawaii products are distributed across the United States and internationally through natural and specialty retailers, healthcare professionals, and e-commerce platforms including and ☨ These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Business Wire
4 hours ago
- Business Wire
Simplify Healthcare Launches Xperience1™: A Next-Generation Platform for Benefits Inquiry Management, Powered by Domain-Rich AI
AURORA, Ill.--(BUSINESS WIRE)-- Simplify Healthcare, a recognized leader in enterprise software solutions for Payers, today announced Xperience1™, a groundbreaking solution designed to transform the benefits inquiry experience for health plan members, providers, brokers, and other stakeholders. This next-generation CX platform delivers clear, real-time, plain-language responses to complex benefit questions—across all channels and user roles. Built on the trusted Simplify Health Cloud™, Xperience1™ unifies the strengths of the company's flagship platforms, Service1™ and Experience1™, into one intelligent, AI-powered customer experience platform. It enables payers to streamline and elevate benefits communication across the entire member journey—from plan shopping and enrollment to customer service and self-service. 'Xperience1™ is the natural next step in our mission to transform how healthcare consumers understand, navigate, and experience their benefits,' said Ashish Desai, EVP and GM, Xperience1™, Simplify Healthcare. 'It delivers measurable business impact by significantly reducing call duration, improving first call resolution (FCR), and ensuring clear, consistent, member-friendly communication.' Unlike generic GenAI-based solutions that are prone to hallucinations, Xperience1™ is built on a robust architecture featuring a sophisticated domain-rich data foundation, intelligent content management, an interactive AI framework, and a built-in health literacy model. These capabilities enable it to provide accurate, context-aware, and curated responses—minimizing the risk of misinformation. ' With Xperience1™, we're going further—not starting over,' added Mohammed Vaid, CEO and Chief Solution Architect, Simplify Healthcare. ' We've reimagined two trusted solutions into one unified platform, delivering on our promise to bring clarity to complexity.' The launch of Xperience1™ underscores Simplify Healthcare's commitment to innovation and its mission to simplify the healthcare experience. To learn more about Xperience1™, visit About Simplify Healthcare Simplify Healthcare helps payers achieve growth and operational efficiency through its industry-leading platform, proven processes, and deep expertise. Founded in 2008, the company tackles some of the most complex challenges in healthcare by connecting the front, middle, and back office through a platform-centric, payer-focused approach.
Business Wire
4 hours ago
- Business Wire
Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
CHICAGO--(BUSINESS WIRE)--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions being the development and research of innovative total body PET/CT technology. i This effort is expected to explore new clinical pathways and help enhance patient outcomes through innovative imaging solutions. 'This technology is designed to offer a level of sensitivity and spatial resolution that can change how we design and conduct molecular imaging studies,' says Dr. Andrei Iagaru, Division Chief of Nuclear Medicine and Molecular Imaging, Stanford Medicine. Share 'PET/CT has revolutionized the way we understand and treat disease by allowing us to visualize biological processes at the cellular level,' explains Dr. Quynh-Thu Le, interim Chair of the Department of Radiology, Stanford Medicine. 'With total body PET/CT, we can explore new frontiers. Not only do we expect it will be faster, but we also believe it will fundamentally expand what is possible in translational research.' Molecular imaging – and specifically the utilization of PET/CT scanners – offers opportunities for precision care across various disease states. It supports theranostics in oncology for advanced prostate cancer treatment, helps streamline radiation oncology workflows, aids in beta amyloid imaging for Alzheimer's evaluation and monitoring, and assists in myocardial perfusion evaluation for diagnosing coronary artery disease. Unlike other imaging procedures, PET/CT technology visualizes, characterizes, and quantifies biological processes at the cellular level, aiding in early disease identification, detailed assessment, and treatment planning. It is a non-invasive solution, providing critical insights that help enhance patient care and can support accelerated drug development. 'This technology is designed to offer a level of sensitivity and spatial resolution that can change how we design and conduct molecular imaging studies,' adds Dr. Andrei Iagaru, Division Chief of Nuclear Medicine and Molecular Imaging, Stanford Medicine. 'For example, such technological characteristics can create opportunities to reduce anesthesia use in pediatric imaging by dramatically shortening scan times and enable the exploration of dual-tracer studies and early diagnosis with far greater precision. Total body PET/CT technology is an ideal tool to evaluate biodistribution and dosimetry of new PET radiopharmaceuticals in our first human studies.' Knowing the potential of this technology, researchers at Stanford Medicine and engineers at GE HealthCare aim to advance a next-generation PET/CT designed to provide new opportunities to improve diagnosis, staging, therapeutic planning, and evaluation of treatment response across various care pathways. By leveraging the technology's capabilities, both institutions believe it has the potential to drive new clinical pathways, expedite the development and translation of new diagnostic and therapeutic agents, support existing molecular imaging and theranostics applications, and promote enhanced healthcare system efficiency. 'The high throughput we anticipate from this technology could ultimately help improve access for our patients and reduce wait times to their next appointment,' says Dr. Erin Grady, incoming Division Chief of Nuclear Medicine and Molecular Imaging, Stanford Medicine. GE HealthCare's total body PET/CT innovation In collaboration with a select group of leading healthcare institutions around the world, GE HealthCare aims to demonstrate how total body PET/CT imaging can overcome barriers that previously hindered widespread adoption of PET/CT beyond oncology. This initiative seeks to expand the use of PET with the goal of leveraging ultra-high sensitivity total body PET/CT technology to push the boundaries of oncology by significantly reducing scan time and the injected dose – important considerations for all patients, but particularly vulnerable patients like pediatrics, where ultra-fast scans can allow reduction in anesthesia and sedation in children. To support this advanced research, encourage new discoveries, and meet growing clinical demands, GE HealthCare designed its total body PET/CT technology with the goal of enabling ultra-low dose scans; fast acquisitions; multi organ dynamic imaging; and dual tracer imaging. All important factors that help improve diagnosis confidence. In parallel, the technology aims to improve healthcare system efficiency by enhancing clinical workflows, supporting routine clinical practice, and improving operational efficiency. 'At GE HealthCare, innovation is in our DNA. Our total body PET/CT technology represents the next chapter in our enduring commitment to advancing medical imaging,' adds Jean-Luc Procaccini, President & CEO, Molecular Imaging and Computed Tomography, GE HealthCare. 'We're proud to collaborate with world-class institutions to explore new clinical frontiers in oncology and beyond. Together with our MIM software solutions, we're designing flexible, AI-enhanced tools that not only aim to enhance diagnostic confidence and operational efficiency but also help clinicians deliver more precise, personalized care that can truly improve patient outcomes.' GE HealthCare has a long-standing history of and commitment to pioneering next-generation imaging technology. From the first commercially available PET/CT solution, Discovery LS, ii to the development of the first silicon-based photon counting computed tomography (CT) prototype, iii GE HealthCare continues to push the boundaries of medical imaging for the benefit of clinicians and patients worldwide. As such, GE HealthCare is at the forefront of driving a connected healthcare transformation and revolutionizing precision care. For more information on GE HealthCare's impressive Molecular Imaging portfolio, visit About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™.
